0

Journal Articles

in Drug Prescribing Behavior
 21-40 of 81 Articles
Medical News & Perspectives |  March 09, 2011
FDA Takes Slow Road Toward Withdrawal of Drug Approved With Fast-Track Process
Mike Mitka
JAMA. 2011;305(10):982-984. doi:10.1001/jama.2011.269.
Capitol Health Call |  November 10, 2010
Questions for CVS Caremark
Mike Mitka
JAMA. 2010;304(18):2005. doi:10.1001/jama.2010.1606.
From the Centers for Disease Control and Prevention |  August 04, 2010 FREE
Emergency Department Visits Involving Nonmedical Use of Selected Prescription Drugs—United States, 2004-2008
JAMA. 2010;304(5):514-516. doi:.
Commentary |  July 14, 2010
Physician Competencies for Prescribing Lifestyle Medicine
Liana Lianov, MD, MPH; Mark Johnson, MD, MPH
JAMA. 2010;304(2):202-203. doi:10.1001/jama.2010.903.
Medical News and Perspectives |  July 07, 2010
Program Seeks to Enlist Physicians to Flag Questionable Promotion of Drugs
Mike Mitka
JAMA. 2010;304(1):28-29. doi:10.1001/jama.2010.861.
Medical News & Perspectives |  May 19, 2010
Studies Shed Light on Risks and Trends in Pediatric Antipsychotic Prescribing
Bridget M. Kuehn
JAMA. 2010;303(19):1901-1903. doi:10.1001/jama.2010.596.
Medical News & Perspectives |  April 28, 2010
Questionable Antipsychotic Prescribing Remains Common, Despite Serious Risks
Bridget M. Kuehn
JAMA. 2010;303(16):1582-1584. doi:10.1001/jama.2010.453.
Medical News & Perspectives |  February 10, 2010
Safety Plan for Opioids Meets Resistance
Bridget M. Kuehn
JAMA. 2010;303(6):495-497. doi:10.1001/jama.2010.71.
Capitol Health Call |  January 13, 2010
Price Hikes Probed
Mike Mitka
JAMA. 2010;303(2):125. doi:10.1001/jama.2009.1954.
Medical News & Perspectives |  June 24, 2009
FDA Tells Drug and Device Makers to Give Balanced Picture of Risks in Ads, Labels
Bridget M. Kuehn
JAMA. 2009;301(24):2541. doi:10.1001/jama.2009.881.
Capitol Health Call |  June 10, 2009
Enhancing FDA Inspections
Mike Mitka
JAMA. 2009;301(22):2318. doi:10.1001/jama.2009.782.
Capitol Health Call |  May 13, 2009
Unbiased Drug Information
Mike Mitka
JAMA. 2009;301(18):1868. doi:10.1001/jama.2009.606.
Commentary |  February 25, 2009
Promoting More Conservative Prescribing
Gordon D. Schiff, MD; William L. Galanter, MD, PhD
JAMA. 2009;301(8):865-867. doi:10.1001/jama.2009.195.
INCLUDES: CME
Commentary |  November 26, 2008
Benefits and Risks of Drug Treatments:  How to Combine the Best Evidence on Benefits With the Best Data About Adverse Effects
Jan P. Vandenbroucke, MD, PhD; Bruce M. Psaty, MD, PhD
JAMA. 2008;300(20):2417-2419. doi:10.1001/jama.2008.723.
Editorial |  October 22, 2008
Prescription Drugs, Products Liability, and Preemption of Tort Litigation
JAMA. 2008;300(16):1939-1941. doi:10.1001/jama.2008.513.
Capitol Health Call |  September 17, 2008
Academic Detailing Bill
Mike Mitka
JAMA. 2008;300(11):1290. doi:10.1001/jama.300.11.1290-c.
Capitol Health Call |  June 11, 2008
Consumer Drug Ads
Mike Mitka
JAMA. 2008;299(22):2620. doi:10.1001/jama.299.22.2620-d.
Health Agencies Update |  January 30, 2008
Carbamazepine Prescribing
JAMA. 2008;299(4):399. doi:10.1001/jama.2008.6.
Original Contribution |  January 02, 2008 FREE
Trends in Opioid Prescribing by Race/Ethnicity for Patients Seeking Care in US Emergency Departments
Mark J. Pletcher, MD, MPH; Stefan G. Kertesz, MD, MSc; Michael A. Kohn, MD, MPP; et al.
JAMA. 2008;299(1):70-78. doi:10.1001/jama.2007.64.
Clinical Review |  September 19, 2007 FREE
Prescribing Amiodarone:  An Evidence-Based Review of Clinical Indications
Patricia Vassallo, MD; Richard G. Trohman, MD
JAMA. 2007;298(11):1312-1322. doi:10.1001/jama.298.11.1312.
INCLUDES: CME

Sign In

Register for a FREE personal account

and access these and other features:

Register Now

Want to Subscribe?

Learn More about subscription options.

Don't have Access?

Register and get free email Table of Contents alerts, saved searches, PowerPoint downloads, CME quizzes, and more

Subscribe for full-text access to content from 1998 forward and a host of useful features

Activate your current subscription (AMA members and current subscribers)

From The JAMA Network
JAMA Internal Medicine
Viewpoint  |  May 13, 2013
Adulterated Sexual Enhancement Supplements:  More Than Mojo
Pieter A. Cohen, MD; Bastiaan J. Venhuis, PhD
JAMA Internal Medicine
Research Letters  |  April 22, 2013
Trends in On-label and Off-label Modafinil Use in a Nationally Representative Sample
Renée A. Peñaloza, MS; Urmimala Sarkar, MD, MPH; David M. Claman, MD; et al.
JAMA Internal Medicine
Original Investigation  |  March 18, 2013
Prolonged Antibiotic Treatment in Long-term Care:  Role of the Prescriber
Nick Daneman, MD, MSc; Andrea Gruneir, PhD; Susan E. Bronskill, PhD; et al.
JAMA Internal Medicine
Invited Commentary  |  March 18, 2013
Improving Prescribing of Antibiotics in Long-term Care:  Comment on “Prolonged Antibiotic Treatment in Long-term Care”
Carmel M. Hughes, PhD; Michael M. Tunney, PhD
© 2013 American Medical Association. All Rights Reserved.
Powered bySilverchair Information Systems